Literature DB >> 25236665

Human endotoxin administration as an experimental model in drug development.

A F Suffredini1, R J Noveck2.   

Abstract

Linking human physiology to inflammatory mechanisms discovered in vitro or in animal models is essential to determine their importance. Innate immunity underlies many of these inflammatory responses in health and disease. Bacterial endotoxin is the quintessential trigger of innate immune responses. When administered to humans, endotoxin has been an important means of demonstrating key inflammatory mechanisms in vivo. Furthermore, endotoxin challenges have provided opportunities to test the effects of novel inflammation-modifying agents in humans.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25236665     DOI: 10.1038/clpt.2014.146

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  18 in total

Review 1.  Endotoxemia-menace, marker, or mistake?

Authors:  Robert S Munford
Journal:  J Leukoc Biol       Date:  2016-07-14       Impact factor: 4.962

2.  The Lung is a Host Defense Niche for Immediate Neutrophil-Mediated Vascular Protection.

Authors:  Bryan G Yipp; Jung Hwan Kim; Ronald Lima; Lori D Zbytnuik; Björn Petri; Nick Swanlund; May Ho; Vivian G Szeto; Tamar Tak; Leo Koenderman; Peter Pickkers; Anton T J Tool; Taco W Kuijpers; Timo K van den Berg; Mark R Looney; Matthew F Krummel; Paul Kubes
Journal:  Sci Immunol       Date:  2017-04-28

3.  Low Plasma Gelsolin Concentrations in Chronic Granulomatous Disease.

Authors:  John Audley; Emily F Gliniewicz; Kol A Zarember; Hanna S Hong; Gal Wald; Douglas B Kuhns; Elizabeth Kang; Harry L Malech; Anthony F Suffredini; Robert J Noveck; Mark J Dinubile; Susan L Levinson; Thomas P Stossel; John I Gallin
Journal:  Inflammation       Date:  2020-09-04       Impact factor: 4.092

4.  Macrophages Educated with Exosomes from Primed Mesenchymal Stem Cells Treat Acute Radiation Syndrome by Promoting Hematopoietic Recovery.

Authors:  John A Kink; Matthew H Forsberg; Sofiya Reshetylo; Soroush Besharat; Charlie J Childs; Jessica D Pederson; Annette Gendron-Fitzpatrick; Melissa Graham; Paul D Bates; Eric G Schmuck; Amish Raval; Peiman Hematti; Christian M Capitini
Journal:  Biol Blood Marrow Transplant       Date:  2019-08-05       Impact factor: 5.742

5.  Endotoxin for Alcohol Research: A Call for Experimental Medicine Using Lipopolysaccharide Challenge.

Authors:  Elizabeth M Burnette; Erica N Grodin; Naomi I Eisenberger; Lara A Ray
Journal:  Alcohol Alcohol       Date:  2021-10-29       Impact factor: 2.826

Review 6.  Advances in Gut Microbiome Research, Opening New Strategies to Cope with a Western Lifestyle.

Authors:  Gina P Rodriguez-Castaño; Alejandro Caro-Quintero; Alejandro Reyes; Fernando Lizcano
Journal:  Front Genet       Date:  2017-01-10       Impact factor: 4.599

7.  Concurrent Immune Suppression and Hyperinflammation in Patients With Community-Acquired Pneumonia.

Authors:  Xanthe Brands; Bastiaan W Haak; Augustijn M Klarenbeek; Natasja A Otto; Daniël R Faber; René Lutter; Brendon P Scicluna; W Joost Wiersinga; Tom van der Poll
Journal:  Front Immunol       Date:  2020-05-06       Impact factor: 7.561

8.  Differential in vivo activation of monocyte subsets during low-grade inflammation through experimental endotoxemia in humans.

Authors:  B Thaler; P J Hohensinner; K A Krychtiuk; P Matzneller; L Koller; M Brekalo; G Maurer; K Huber; M Zeitlinger; B Jilma; J Wojta; W S Speidl
Journal:  Sci Rep       Date:  2016-07-22       Impact factor: 4.379

9.  Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation.

Authors:  James N Fullerton; Elisabetta Segre; Roel P H De Maeyer; Alexander A N Maini; Derek W Gilroy
Journal:  J Vis Exp       Date:  2016-05-16       Impact factor: 1.355

10.  Intravenous administration of LPS activates the kynurenine pathway in healthy male human subjects: a prospective placebo-controlled cross-over trial.

Authors:  Vincent Millischer; Matthias Heinzl; Anthi Faka; Michael Resl; Ada Trepci; Carmen Klammer; Margot Egger; Benjamin Dieplinger; Martin Clodi; Lilly Schwieler
Journal:  J Neuroinflammation       Date:  2021-07-17       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.